137
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Changes of Urinary Cytokines in Non-Diabetic Obese Patients After Laparoscopic Sleeve Gastrectomy

ORCID Icon, , , , , , , , ORCID Icon, & ORCID Icon show all
Pages 825-831 | Published online: 10 Mar 2021

References

  • Goktas Z, Moustaid-Moussa N, Shen C, Boylan M, Mo H, Wang S. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;10(4):69.
  • Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20(23):6008. doi:10.3390/ijms20236008
  • Lewko WM, Oldham RK. Cytokines. In: Oldham RK, Dillman RO, editors. Principles of Cancer Biotherapy. Dordrecht: Springer; 2009.
  • Hunley TE, Ma L, Kon V. Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens. 2010;19(3):227–234. doi:10.1097/MNH.0b013e3283374c09
  • Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokines. 2009;47(1):37–42. doi:10.1016/j.cyto.2009.04.001
  • Qureshi A, Frankel AH, Tam FWK. CCL18/PARC, a novel cytokine present in urine of diabetic patients, may be involved in regulation of inflammation and fibrosis in diabetic nephropathy. Am Soc Nephrol Renal Week. 2007.
  • Bruchfeld A, Carrero JJ, Qureshi AR, et al. Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. Mol Med. 2009;15(3–4):70–75. doi:10.2119/molmed.2008.00109
  • Hell E, Miller K. Criteria for selection of patients for bariatric surgery. Zentralbl Chir. 2002;127(12):1035–1037. doi:10.1055/s-2002-36375
  • Yermilov I, McGory ML, Shekelle PW, Ko CY, Maggard MA. Appropriateness criteria for bariatric surgery: beyond the NIH guidelines. Obesity (Silver Spring). 2009;17(8):1521–1527. doi:10.1038/oby.2009.78
  • Sjöström L, Lindroos AK, Peltonen M, et al.; Obese subjects study scientific group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–2693. Swedish. doi:10.1056/NEJMoa035622
  • Kulick D, Hark L, Deen D. The bariatric surgery patient: a growing role for registered dietitians. J Am Diet Assoc. 2010;110(4):593–599. doi:10.1016/j.jada.2009.12.021
  • Hoyuela C. Five-year outcomes of laparoscopic sleeve gastrectomy as a primary procedure for morbid obesity: a prospective study. World J Gastrointest Surg. 2017;9(4):109–117. doi:10.4240/wjgs.v9.i4.109
  • Ahmed MH, Byrne CD. Bariatric surgery and renal function: a precarious balance between benefit and harm. Nephrol Dial Transplant. 2010;25(10):3142–3147. doi:10.1093/ndt/gfq347
  • Bueter M, Dubb SS, Gill A, et al. Renal cytokines improve early after bariatric surgery. Br J Surg. 2010;97(12):1838–1844. doi:10.1002/bjs.7264
  • Lee H, Lee S, Choue R. Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr. 2013;16(3):143–152. doi:10.5223/pghn.2013.16.3.143
  • Baracho NCDV, Silveira KD, Rocha NP, et al. Urinary cytokine profiles according to the site of blockade of the renin-angiotensin system in nephrectomized rats. J Bras Nefrol. 2017;39(2):108–118. doi:10.5935/0101-2800.20170028
  • Li J, Tang Y, Tang PMK, et al. Blocking macrophage migration inhibitory factor protects against cisplatin-induced acute kidney injury in mice. Mol Ther. 2018;26(10):2523–2532. doi:10.1016/j.ymthe.2018.07.014
  • Andres-Hernando A, Dursun B, Altmann C, et al. Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy. Nephrol Dial Transplant. 2012;27(12):4339–4347. doi:10.1093/ndt/gfs256
  • Eisenhardt SU, Thiele JR, Bannasch H, Stark GB, Peter K. C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle. 2009;8(23):3885–3892. doi:10.4161/cc.8.23.10068
  • Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010;2010:535918. doi:10.1155/2010/535918
  • Kones R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease–a perspective. Drug Des Devel Ther. 2010;4:383–413. doi:10.2147/DDDT.S10812
  • McDonald S, Maguire G, Duarte N, Wang XL, Hoy W. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian aboriginal community. Clin Sci (Lond). 2004;106(2):121–128. doi:10.1042/CS20030186
  • Schraufstatter IU, Zhao M, Khaldoyanidi SK, DiScipio RG. The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum. Immunology. 2012;135(4):287–298. doi:10.1111/j.1365-2567.2011.03541.x
  • Eriksson HD, Petrus P, Gao H, et al. Adipose and circulating CCL18 levels associated with metabolic risk factors in women. J Clin Endocrinol Metab. 2016;101(11):4021–4029. doi:10.1210/jc.2016-2390
  • Forssmann U, Magert HJ, Adermann K, Escher SE, Forssmann WG. Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15. J Leukoc Biol. 2001;70:357–366.
  • Kitagawa K, Wada T, Furuichi K, et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol. 2004;165(1):237–246. doi:10.1016/S0002-9440(10)63292-0
  • Li JH, Tang Y, Lv J, et al. Macrophage migration inhibitory factor promotes renal injury induced by ischemic-reperfusion. J Cell Mol Med. 2019;23(6):3867–3877. doi:10.1111/jcmm.14234
  • Rojano-Rodríguez ME, Valenzuela-Salazar C, Cárdenas-Lailson LE, Romero Loera LS, Torres-Olalde M, Moreno-Portillo M. C-reactive protein level in morbidly obese patients before and after bariatric surgery. Rev Gastroenterol Mex. 2014;79(2):90–95. doi:10.1016/j.rgmx.2013.11.002
  • Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters, and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr. 2006;25(3):400–408. doi:10.1016/j.clnu.2005.11.014
  • de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL, PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26(Suppl 4):S21–4. doi:10.1038/sj.ijo.0802213
  • Ritz E. Bariatric surgery and the kidney—much benefit, but also potential harm. Clin Kidney J. 2013;6(4):368–372. doi:10.1093/ckj/sfs161
  • Holcomb CN, Goss LE, Almehmi A, Grams JM, Corey BL. Bariatric surgery is associated with renal function improvement. Surg Endosc. 2018;32(1):276–281. doi:10.1007/s00464-017-5674-y
  • Kun L, Zou J, Zhibin Y, Jianzhong D, Han X. Laparoscopic sleeve gastrectomy improves glomerular filtration rate in morbidly obese patients with impaired kidney function. J Am Coll Surg. 2017;225(4):e3.
  • Li K, Zou J, Ye Z, et al. Effects of bariatric surgery on renal function in obese patients: a systematic review and meta-analysis. PLoS One. 2016;11(10):e0163907. doi:10.1371/journal.pone.0163907
  • Friedman AN, Strother M, Quinney SK, et al. Measuring the glomerular filtration rate in obese individuals without overt kidney disease. Nephron Clin Pract. 2010;116:c224–34. doi:10.1159/000317203
  • Prigent A. Monitoring renal function and limitations of renal function tests. Semin Nucl Med. 2008;38(1):32–46. doi:10.1053/j.semnuclmed.2007.09.003